CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

RATIONALE: CI-1040 may stop the growth of tumors by blocking the enzymes necessary for cancer cell growth and by stopping blood flow to the tumor.
PURPOSE: Phase II trial to study the effectiveness of CI-1040 in treating patients who have metastatic or unresectable breast, colon, pancreatic, or non-small cell lung cancer.

研究依据：CI-1040可通过阻断癌细胞生长所必需的酶、切断肿瘤供血，从而抑制肿瘤生长。
试验目的：开展II期临床试验，评估CI-1040治疗转移性或不可切除性乳腺癌、结直肠癌、胰腺癌及非小细胞肺癌患者的有效性。